Olink

Olink®
Part of Thermo Fisher Scientific

Storm of Cardiovascular Markers After LPS Administration in Human Volunteers

Journal of Cardiovascular Translational Research, 2021

Resl M., Heinzl M., Klammer C., Egger M., Feldbauer R., Pohlhammer J., Dieplinger B., Clodi M.

Disease areaApplication areaSample typeProducts
CVD
Pathophysiology
Plasma
Olink Target 96

Olink Target 96

Abstract

Acute infections are associated with an elevated cardiovascular risk. However, little is known about the interactions of acute inflammatory responses and the cardiovascular system. We therefore aimed to evaluate effects of acute inflammatory stimuli mediated by LPS administration on a set of 89 cardiovascular biomarkers. A single-blinded, placebo-controlled cross-over study using the human endotoxin model was performed. Ten healthy men were administered lipopolysaccharide (LPS) or placebo on two different study days after an overnight fast. Eighty-nine different cardiovascular biomarkers were measured repetitively over 48 h. Out of 89 cardiovascular biomarkers, 54 markers were significantly influenced by LPS infusion. The observed biomarker response to inflammation was more pronounced and complex than anticipated. In conclusion, our data show that the cardiovascular system is under enormous distress in response to experimental low-dose inflammation in humans, as demonstrated by a significant effect on 54 of the 89 biomarkers tested.

Read publication ↗